Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02385006Completed
Open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Thromboelastogram (ROTEM) channels (APTEM, EXTEM, INTEM, FIBTEM) monitoring at 48 hours. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02385006.